Arvee Laboratories (India) Ltd

Shares of Arvee Laboratories (India) Ltd surged to hit the upper circuit limit on 3 February 2026, propelled by robust buying interest and a maximum daily gain of 3.48%. The stock closed at ₹161.01, marking a ₹5.42 rise from the previous close, reflecting heightened investor enthusiasm despite the company’s current strong sell rating.

Arvee Laboratories (India) Ltd witnessed a robust surge in its share price on 1 Feb 2026, hitting the upper circuit limit of 5%, closing at ₹164.72. This sharp rally was driven by intense buying interest, resulting in a maximum daily gain and a regulatory trading freeze to contain volatility. Despite its micro-cap status and a recent downgrade to a Strong Sell rating, the stock outperformed its sector and the broader Sensex, signalling notable market attention.

Arvee Laboratories (India) Ltd witnessed robust buying interest on 28 Jan 2026, hitting its upper circuit limit with a maximum daily gain of 4.98%. The stock closed at ₹156.53, marking a significant outperformance against its sector and the broader market, driven by unrelenting demand and a regulatory freeze on further price movement.

Arvee Laboratories (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Shares of Arvee Laboratories (India) Ltd plunged to their lower circuit limit on 21 Jan 2026, reflecting intense selling pressure and panic among investors. The stock declined by 5.0%, closing at ₹152.64, marking its maximum permissible daily loss and signalling a sharp negative sentiment in the Chemicals & Petrochemicals sector.

Shares of Arvee Laboratories (India) Ltd plunged to their lower circuit limit on 14 Jan 2026, closing at ₹179.45, marking a maximum daily loss of 5.0%. The stock faced intense selling pressure, with panic selling dominating trade and leaving a significant unfilled supply on the order books. This sharp decline comes despite the broader Chemicals & Petrochemicals sector showing resilience, underscoring company-specific concerns.

Arvee Laboratories (India) Ltd surged to its upper circuit limit on 12 Jan 2026, registering a maximum daily gain of 5.0% as robust buying interest propelled the stock to ₹199.52. This sharp rally comes despite a challenging sector backdrop and a recent downgrade in the company’s mojo rating, highlighting a complex interplay of market forces and investor sentiment.

Arvee Laboratories (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 January 2026, providing investors with the latest insights into its performance and outlook.

Shares of Arvee Laboratories (India) Ltd plunged to their lower circuit limit on 1 Jan 2026, registering a maximum daily loss of 5.0% amid intense selling pressure and panic among investors. The stock closed at ₹202.67, down ₹10.66 from the previous close, reflecting a sharp underperformance relative to its sector and the broader market.

Shares of Arvee Laboratories (India) Ltd plunged to their lower circuit limit on 31 Dec 2025, reflecting intense selling pressure and panic among investors. The stock recorded a maximum daily loss of 4.69%, underperforming its sector and the broader market, as unfilled supply overwhelmed demand in a thinly traded session.

Shares of Arvee Laboratories (India) Ltd, a micro-cap player in the Chemicals & Petrochemicals sector, plunged sharply on 30 Dec 2025, hitting the lower circuit limit of ₹221.94. The stock recorded a maximum daily loss of 5.0%, underperforming its sector and the broader market amid intense selling pressure and a marked decline in investor participation.

Shares of Arvee Laboratories (India) Ltd, a micro-cap player in the Chemicals & Petrochemicals sector, faced intense selling pressure on 29 Dec 2025, hitting the lower circuit limit and registering a maximum daily loss of 3.86%. The stock's performance notably lagged behind its sector and the broader Sensex index, reflecting a day marked by panic selling and unfilled supply.

Shares of Arvee Laboratories (India) Ltd, a micro-cap player in the Chemicals & Petrochemicals sector, plunged to their lower circuit limit on 26 Dec 2025, reflecting intense selling pressure and a sharp decline in investor participation. The stock closed at ₹242.13, marking a maximum daily loss of 5.0% and underperforming its sector and broader market benchmarks.

Arvee Laboratories (India) Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.

Shares of Arvee Laboratories (India) Ltd, a player in the Chemicals & Petrochemicals sector, plunged to their lower circuit limit on 22 Dec 2025, reflecting intense selling pressure and a sharp decline in investor sentiment. The stock recorded a maximum daily loss of 9.54%, closing at ₹263.05, signalling a significant market reaction within a micro-cap context.

Arvee Laboratories (India) Ltd witnessed a remarkable surge in its share price on 19 Dec 2025, hitting the upper circuit limit of 14.72% and closing at ₹278.00. This strong buying pressure propelled the stock to a new 52-week high of ₹290.78, significantly outperforming its Chemicals & Petrochemicals sector peers and broader market indices.

Shares of Arvee Laboratories (India) Ltd surged to their upper circuit limit on 17 Dec 2025, reflecting intense buying interest and a maximum permissible daily gain of 20%. The stock closed at ₹210.51, marking a significant move within the Chemicals & Petrochemicals sector, while broader indices such as the Sensex and the sector itself recorded marginal declines.

Arvee Laboratories (India) Ltd has witnessed an exceptional surge in buying activity, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights intense investor interest and suggests the possibility of a sustained multi-day circuit scenario.